
6 Steps That Helped Me Lead Through Three Global Crises
Feeling afraid is natural. But feeling afraid every day? That's not sustainable, especially for entrepreneurs.
Opinions expressed by Entrepreneur contributors are their own.
In 2000, I was head of the first fintech in Mexico, Finanzas Web. A company so innovative that we survived the market collapse when the dot-com bubble burst because we had capital reserves and a clear execution plan.
In 2008, the Great Recession hit, and I was in the eye of the hurricane with a business specializing in mortgages for the Hispanic market. When the bank cut our lending overnight, I lost the company and was left with $1 million in personal debt.
Third time's the charm, right? In 2020, amid COVID, my current company, Growth Institute, was prepared. We doubled revenue and made the Inc. 5000 list for the third consecutive year. We came out stronger than ever.
Same CEO. Same world. Different outcomes.
So, what changed? Better systems, deeper awareness and a disciplined mindset.
Related: Fear Can Hold Us Back – But It Can Also Drive Us Forward. Here's How to Turn Fear Into Fuel.
Step 1: Name the fear
The first step in managing fear is naming it. Psychologists Justin Milano and Dan Cordaro emphasize that high-performing entrepreneurs don't deny fear — they study it. When fear arises, don't suppress it. Ask: What's the fear? Where do I feel it in my body? Is it rooted in a real threat or in a future that may never happen?
Anxiety often stems from mental loops rather than concrete facts. For instance: "What if we run out of cash?" or "What if the product fails?" These fears narrow your thinking, reducing your ability to problem-solve. When you label the fear, you reclaim power over it.
Step 2: Shift the lens
Fear signals potential loss. But what if it's pointing to opportunity?
Milano and Cordaro outline three common fear mindsets:
Scarcity: Believing there's never enough.
Aversion: Resisting reality as it is.
Unworthiness: Feeling inadequate.
The moment you shift from "What might I lose?" to "What could I gain?" you take back control.
Related: 3 Steps to Overcome the Fear of Uncertainty and Daily Stress
Step 3: Build systems before the storm
Jim Collins coined the term Return on Luck, which he defines as the ability to turn unexpected events—good or bad — into momentum for scaling. And here's the key insight: successful and unsuccessful companies receive the same amount of luck. The difference is in what they do with it.
How to increase your Return on Luck:
Stay alert: Opportunities rarely look like opportunities at first.
Act with discipline: Minimize emotions. Rely on data and strategy.
Learn fast: Every crisis brings a lesson. Are you listening?
Be consistent: Don't change course with every breeze. Discipline sets you free.
ROL allowed my companies to collapse or scale, depending on our preparedness. So ask yourself:
Do we have a system for cash flow management?
Do we have KPIs we monitor weekly?
Can our team execute without micromanagement?
Luck is unpredictable — but your response to it isn't. Adopting a disciplined mindset can turn uncertainty into growth and lasting success. Train for chaos before it arrives.
Step 4: Tighten your execution disciplines
In times of uncertainty, operational discipline becomes your safety net. Think of your business like a car. Without a dashboard — clear KPIs, priorities and communication rhythms — you're driving blind.
Go back to the basics:
Define your top priorities.
Hold daily and weekly huddles to maintain alignment.
Make your metrics visible and reviewed consistently.
Beyond the mechanics, reinforce your company's strategy and values in every meeting. Be vocal. Be repetitive. Leadership means becoming a constant messenger of your vision.
And don't just trust your gut. Use data. In uncertain markets, instinct can be misleading. Stay alert to trends, benchmark your performance, and course-correct early.
Finally, empower your team. Give clear direction, then step back. Agility comes from confident, decentralized execution, not from micromanagement.
Related: Leading With Transparency in Times of Uncertainty
Step 5. Lead with transparency and strategy
In crisis, communication becomes your most powerful tool. It's not enough to have a strategy. You must communicate it clearly and consistently.
That means:
Articulating your vision in simple, repeatable terms
Listening to your team's concerns without judgment
Staying transparent during tough calls
Leadership is not about having all the answers but showing the path forward.
Step 6: Negotiate like a pro
During economic instability, one of the most overlooked levers is your supplier relationships. While most CEOs rush to cut headcount or pause marketing, the smart ones call their vendors.
Consider this approach:
"Like you, we're feeling the pressure. Let's revisit our agreement and find a win-win."
You might be surprised how flexible suppliers become when the relationship is strong. Here are quick wins to explore:
Extended payment terms
Lower minimum commitments
Locked-in pricing for more extended periods
Proactive negotiation in times of uncertainty isn't a risk. It's strategic leadership.
You can't eliminate fear, but you can lead through it
Fear doesn't disappear as you scale; it evolves. However, so can your strategies and resilience. The best entrepreneurs don't wait for confidence to act. They act their way into confidence.
As someone who's experienced three major crises and emerged stronger on the other side, my advice is this: Don't try to outrun fear. Make it your ally.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
30 minutes ago
- Yahoo
City's independent watchdog to be replaced as several reports remain under wraps
Jun. 13—The city of Albuquerque's inspector general is out of a job after months of conflict with an oversight committee that has yet to make public six completed investigations into alleged misconduct or malfeasance at City Hall. The city's Accountability in Government Oversight Committee put Inspector General Melissa Santistevan on administrative leave with pay on May 13 after deciding not to recommend she be retained for another four years. Her contract expires June 21, and three new OIG candidates are up for City Council consideration. At the same time, the committee sent the six OIG reports to an outside contractor for a "quality assurance review," according to a city spokeswoman. The city will pay the firm REDW up to $30,205 for the work as an "independent consultant." The reports may be made public after the committee's next meeting on July 29 but could conceivably be revised by the next inspector general. The City Council is set to consider the OIG appointment at its meeting Monday. "Rather than thanking the IG for pointing out problems regarding waste, fraud and abuse so the city could address them, they have chosen to get rid of her for doing her job," said her attorney Edward Hollington on Thursday. Her departure comes as city spending is at an all-time high, with $1.5 billion budgeted for the next fiscal year, and elections for mayor and five council seats set for November. Santistevan was appointed in 2021 after owning an accounting firm and working for the State Auditor's office. She supervised three city investigators. "Although I was not given the opportunity to serve a second term as Inspector General, I remain proud of the work accomplished to promote accountability, transparency, and integrity in local government," Santistevan said in a statement released to the Journal. The OIG in recent years has looked into violations of nepotism, misbilling, abuse of authority and leave policies, and abuse of power. Last November, for instance, the OIG reported uncovering nearly $300,000 in bonuses from a federal child care stabilization grant that went to 27 ineligible city employees, some high-ranking. The program was supposed to help child care providers defray unexpected business costs associated with the COVID pandemic. However, top city officials took issue with the findings and the oversight committee voted 5-0 against approval. The five-member oversight committee, whose volunteer members are appointed by the mayor and City Council, oversees the Office of Inspector General and its employees and conducts searches and screens candidates for the top job. It also oversees the city's internal auditor. Under city ordinance, once the committee receives an investigative report from the OIG, it can approve, defer until the next meeting or vote not to approve the report. Unless deferred, the reports become public. City officials say the committee isn't considered a public body, so its meetings aren't open to the public or advertised. Committee Chair Victor Griego, internal audit director at the University of New Mexico, couldn't be reached on Thursday. Other committee members are Robert Aragon, an Albuquerque attorney; Johnny L. Mangu, a certified public accountant; Esteban A. Aguilar Jr., who serves as vice chair; and Lia Armstrong, an at-large member. Ex-officio members include two top city administrators and two city councilors. The decision to hire someone new for the nonpartisan job comes after Santistevan went public with a notice March 31 noting that the committee had failed to consider and release a total of nine completed OIG investigations. Santistevan stated at the time that the pending reports dealt "with fraud, waste, or abuse that impact our City. Some of these reports have been completed for months without citizen awareness." One investigative report, still unreleased, dated back to October 2024. She urged release of the reports, but Griego, the committee chair, responded in an April notice that the committee had "multiple concerns regarding the quality of the reports and the underlying investigations." The committee released three of the reports in April, deferring action on the rest until May. But no release occurred at that time. Instead, Santistevan was placed on administrative leave, which Griego wrote in a May 13 notice "is in no way a reflection of her work product or job performance. She was an effective manager of the OIG's day-to-day operations, represented our community well as a certified member of the Association of Inspectors General, and is a strong advocate for transparency in government. Rather, the AGOC made this difficult decision to preserve the confidentiality of the work of the OIG and to ensure that work continues unabated during this transition period." An interim member of the office is in charge until a new inspector general takes over. City officials said neither REDW nor the oversight committee has the authority to edit the six pending OIG reports. Asked whether the incoming inspector general will be able to change the reports once appointed, a city spokeswoman said in an email, "The Office of Inspector General has the authority to make any changes to its reports that the Office deems necessary and appropriate, until such time as a report is published." During Santistevan's tenure, her office concluded the city had made an inappropriate purchase of artificial turf for the benefit of a privately owned entity; and determined that a contractor improperly billed the city for services to the homeless and near-homeless. "The work of independent oversight is vital," she stated, "and I remain hopeful that the office will continue to build on the strong foundation we've laid."
Yahoo
35 minutes ago
- Yahoo
Revolutionizing Diagnostics: Digital Pathology Market Growth Report Reach US$1.73 billion by 2030 at 8.0% CAGR
CHICAGO, June 13, 2025 /PRNewswire/ -- The Global Digital Pathology Market is projected to be valued at USD 1.10 billion in 2024 and reach USD 1.73 billion by 2030, growing at a CAGR of 8% according to a new report by The Research Insights. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Digital Pathology Market growth of 8.0% comprises a vast array of Product, Type, Application, End-Use, and Geography which are expected to register strength during the coming years. For More Information and To Stay Updated on The Latest Developments in The Global Digital Pathology Market, Download FREE Sample Pages: Market Overview and Growth Trajectory: Digital Pathology Market Growth: According to an exhaustive report by The Research Insights, the Digital Pathology Market is experiencing significant growth. The worldwide digital pathology market expansion results from multiple technological advancements alongside clinical and systemic changes that mirror a comprehensive shift in diagnostic methods and healthcare service delivery. The rapid integration of artificial intelligence (AI) and machine learning algorithms serves as a key driving force in pathology because they improve diagnostic accuracy while enhancing workflow efficiency and decision-making support. Precision medicine's rising requirement along with individually tailored treatment plans drives the need for digital platforms that integrate histopathological data with genomic and clinical information. The worldwide scarcity of pathologists in developing markets forces healthcare infrastructures to implement digital pathology systems that consolidate diagnostic capabilities and allow for remote consultations through telepathology. The global rise in cancer cases demands the development of diagnostic solutions that operate more quickly and can scale to meet increasing needs. The FDA's regulatory approvals and standardization efforts are helping to validate digital pathology systems which leads to their broader use. The focus on digital health infrastructure and remote healthcare solutions after COVID-19 has solidified digital pathology's essential role in modern diagnostic processes. Rising Prevalence of Chronic Diseases and Cancer:The increasing global prevalence of chronic illnesses such as cancer alongside cardiovascular and autoimmune diseases creates demand for digital pathology through the need for accurate diagnostic results. Cancer stands as a primary focus area because the World Health Organization (WHO) reports that it causes almost 10 million deaths each year. The growing number of cancer cases increases the need for precise histopathological assessments which play a critical role in cancer staging and treatment planning as well as determining patient glass-slide microscopy requires extensive time commitment while demanding substantial labor effort and remains susceptible to mistakes by human operators. Digital pathology allows for complete slide digitization which supports storage capabilities as well as analysis and sharing functions. Digital platforms play an essential role in oncology and chronic disease management through improved diagnostic accuracy and simpler access to second opinions and telepathology. The requirement for high-throughput pathology services becomes even stronger when centralized laboratories need to serve extensive populations. For Detailed Market Insights, Visit: Innovations in Whole Slide Imaging (WSI) technology combined with artificial intelligence (AI) integration are driving major changes in digital pathology:Progress in imaging technology alongside improvements in data storage and artificial intelligence (AI) development is revolutionizing digital pathology. The development of Whole Slide Imaging (WSI) now enables the capture of ultra-high-resolution images which can be stored and distributed with very little delay. After digitization these images become suitable for AI analysis which helps detect patterns and anomalies while classifying tissue types with greater consistency than manual workflows now frequently utilize AI-powered tools to help pathologists identify diseases at early stages while simultaneously quantifying biomarkers and standardizing interpretations. The algorithms designed for breast and prostate cancer detection improve diagnostic efficiency and minimize inter-observer variability by highlighting suspicious regions and providing grading suggestions. Real-time slide sharing capabilities of cloud-based platforms allow institutions to collaborate on diagnostics without being limited by geographic distances. This technological progress improves diagnostic speed and accuracy while shortening turnaround time which is essential for treating life-threatening conditions. Growing Adoption of Telepathology and Remote Consultations:The pandemic hastened digital health technology implementation with digital pathology becoming another beneficiary of this trend. Telepathology has become an essential diagnostic tool due to increasing demands for remote consultations and second opinions. Digital platforms now enable hospitals and laboratories to share slides across regions and countries with specialists which allows for expert reviews and collaborations to occur promptly without needing to transport specimens is emerging as a critical solution to the worldwide inequality in pathology services. Rural regions and areas with limited resources experience a significant lack of trained pathologists. Through digital pathology centralized specialists review cases from distant locations which closes existing healthcare gaps to advance healthcare equity. Digital pathology platforms provide educational institutions with benefits for training and research because students and researchers can access actual slides from any location at any time. Stay Updated on The Latest Digital Pathology Market Trends: Geographical Insights: The North American market achieved a 40.7% share of the global market in 2023 because government-backed initiatives advanced pathology technology. The dominance resulted from continuous R&D funding and the growing implementation of digital imaging technologies. Their influence grew stronger in the region because prominent players focused on creating innovative solutions to meet the needs of the local population. Market expansion is propelled by academic research and disease diagnosis needs for digital pathology because institutions aim to use its capabilities to enhance diagnostic accuracy and treatment results. Between 2024 and 2030 the Asia Pacific region will achieve the highest Compound Annual Growth Rate (CAGR) thanks to increased digitalization activities combined with medical research investments and the growing use of digital imaging technologies in developing economies. The rising occurrence of cancer cases continues to drive market growth which highlights the necessity for new treatment options that will advance market expansion. Global Digital Pathology Market Segmentation and Geographical Insights: Based on Product, the digital pathology market is divided into, Software, Device, and Storage System. The device segment dominated the market share in 2023 with 51.72% and is expected to experience substantial growth over the projected period. Based on Type, the digital pathology market is divided into, Human Pathology, and Veterinary Pathology. The human aspect of digital pathology is playing a pivotal role, accounting for approximately 60.0% market share in 2023. Based on Application, the digital pathology market is divided into, Drug Discovery & Development, Academic Research, and Disease Diagnosis. The academic research segment led the market share in 2023, accounting for 45.7%, and is expected to continue its dominance from 2024 to 2030 due to ongoing research in cancer therapy development and high adoption rates of digital pathology in various studies. Based on End Use, the digital pathology market is divided into, Hospitals, Biotech & Pharma Companies, Diagnostic Labs, and Academic & Research Institutes. The healthcare sector led the market share in 2023 with a notable presence of 36.7%. The Digital Pathology Market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Purchase Premium Copy of Global Digital Pathology Market Size and Growth Report (2024-2030) at: Key Players and Competitive Landscape: The Global Digital Pathology Market is characterized by the presence of several major players, including: Leica Biosystems Nussloch GmbH (Danaher) Hamamatsu Photonics, Inc. Koninklijke Philips N.V. Olympus Corporation F. Hoffmann-La Roche Ltd. Mikroscan Technologies, Inc. Inspirata, Inc. Epredia (3DHISTECH Ltd.) Visiopharm A/S Huron Technologies International Inc. ContextVision AB CellaVision HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO) West Medica Produktions- und Handels- GmbH (West Medica) aetherAI IBEX (IBEX MEDICAL ANALYTICS) SigTuple Technologies Private Limited Morphle Labs, Inc Bionovation Biotech, Inc. These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. Global Digital Pathology Market Recent Developments and Innovations: In March 2024: Koninklijke Philips N.V. (Netherlands) formed an expanded partnership with AWS to create secure, scalable cloud-based digital pathology solutions. The collaboration between AWS and Philips will improve workflow efficiency while ensuring smooth integration with current healthcare systems to provide complete patient care. In February 2024: Roche entered into a partnership with Path AI to build an AI-powered digital pathology algorithm for companion diagnostics. Through this partnership Roche will speed up its capacity to fulfill biopharma companies' needs who seek to create AI-driven companion diagnostics and deliver complete solutions. In March 2023: Agilent Technologies partnered with Hamamatsu Photonics K.K. Agilent Technologies teamed up with Hamamatsu Photonics K.K. to integrate the NanoZoomer range with the S360MD Slide scanner system into their comprehensive digital pathology solution. In March 2022: Roche Diagnostics partnered with SRL Diagnostics. In collaboration with Roche Diagnostics, SRL Diagnostics intended to upgrade its Fortis Memorial Research Institute laboratory facilities. For Region-Specific Market Data, Check Out Brief Sample Pages: Frequently Asked Questions (FAQs): What is the forecasted market size of the Digital Pathology Market in 2030? The forecasted market size of the Digital Pathology Market is USD 1.73 billion in 2030. Who are the leading players in the Digital Pathology Market? The key players in the Digital Pathology Market include, Leica Biosystems Nussloch GmbH (Danaher); Hamamatsu Photonics, Inc.; Koninklijke Philips N.V.; Olympus Corp.; F. Hoffmann-La Roche Ltd.; Mikroscan Technologies, Inc.; Inspirata, Inc.; Epredia (3DHISTECH Ltd.); Visiopharm A/S; Huron Technologies International Inc.; ContextVision AB; HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO); West Medica Produktions- und Handels- GmbH (West Medica); aetherAI; IBEX (IBEX MEDICAL ANALYTICS); SigTuple Technologies Private Limited; Morphle Labs, Inc; and Bionovation Biotech, Inc. What are the major drivers for the Digital Pathology Market? Several key factors are driving this expansion, including the growing adoption of AI-enabled digital pathology. Which is the largest region during the forecasted period in the Digital Pathology Market? The North American market achieved a 40.7% share of the global market in 2023 because government-backed initiatives advanced pathology technology. Which is the largest segment, by product, during the forecasted period in the Digital Pathology Market? The device segment dominated the market share in 2023 with 51.72% and is expected to experience substantial growth over the projected period. Conclusion: Digital imaging advancements and AI along with data analytics improvements lead to major transformations within the global digital pathology market which meets healthcare systems' needs for swifter and more precise diagnostic procedures. The spread of chronic diseases combined with telepathology demand growth and pathologist workforce deficits has sped up the implementation of digital pathology technologies. Modern systems provide the ability for immediate remote medical consultations alongside more efficient data exchange and better-informed decisions through artificial intelligence that analyses medical images. The combination of EHR integration with advanced interoperability and cloud storage solutions leads to better diagnostic precision and operational efficiency. Digital pathology stands as a fundamental component of precision medicine and laboratory automation while global healthcare digitization progresses alongside evolving regulatory frameworks and advanced data security technologies. The market's growth momentum continues as it connects with wider digital health movements and shifts towards value-based care approaches. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders—healthcare providers, diagnostic laboratories, research institutions, pharmaceutical companies, and regulatory agencies—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 1.73 billion by 2030, the Global Digital Pathology Market represents a significant opportunity for AI technology developers, cloud service providers, medical imaging software companies, digital health startups, and telepathology platform vendors. Check out more related studies published by The Research Insights: U.S. And Europe Digital Pathology Market - The US and European digital pathology market is poised for significant growth, driven by increasing efforts to harness this technology for enhanced disease diagnosis and improved pathology practices. Currently valued at USD 578.6 million in 2022, the market is projected to expand at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030. In the US, the FDA has classified digital pathology as Class II devices suitable for primary diagnosis, paving the way for wider adoption. Pathology Laboratories Market: The Global Pathology Laboratories Market is expected to reach at USD 612.22 billion by 2030, according to a new report by The Research Insights. It is projected to expand at a CAGR of 8.1% during the forecast period. This growth is driven by the expanding healthcare infrastructure in developing countries, as well as an increasing demand for regular medical check-ups and enhanced reimbursement policies for diagnostic tests. AI in Pathology Market - The AI in Pathology Market size is set to grow from USD 92.32 million in 2025 to USD 434.16 million by 2034, at a CAGR of 19.07%. The AI for Pathology Market describes how artificial intelligence technologies including machine learning algorithms and neural networks process pathology data to aid clinical decision-making while boosting diagnostic precision and workflow productivity. The medical field of pathology which focuses on disease study and diagnosis through tissue, organ, and fluid examination is experiencing a digital shift through AI integration. Anatomic Pathology Market - The global anatomic pathology market continues to expand its reach, with valued sales reaching USD 30.16 billion in 2022. As we look ahead, the market is projected to experience a significant compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. This surge in growth can be attributed to the increasing adoption of biomarkers in clinical settings, which has revolutionized the way pathologists analyze molecular-level mechanisms. Precision Pathology for Cancer Market: The Research Insights report reveals that Precision pathology for cancer applies advanced technological methods to produce customized diagnostic and therapeutic approaches based on individual tumor biology. This innovative method combines histological, genomic and bioinformatic knowledge to enable healthcare providers to develop individualized treatment plans which lead to improved patient results. Browse More related reports on Healthcare Industry Market Reports – About Us: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1-312-313-8080Blog: Release: News: | Logo: View original content: SOURCE The Research Insights
Yahoo
43 minutes ago
- Yahoo
American Golf owner tees up Endless sale process
The owners of American Golf, Britain's biggest specialist golf retailer, are teeing up a sale of the chain nearly seven years after rescuing the company. Sky News has learnt that Endless, the investment firm, is lining up advisers to oversee an auction. Sources said that Alvarez & Marsal (A&M) was expected to be formally appointed in the coming days. Money blog: American Golf, which trades from 95 stores and employs about 600 people including part-time staff, sells products manufactured by leading golf brands such as Garmin and TaylorMade. It was rescued by Endless in 2018 after a sale process which also involved the Frasers Group billionaire Mike Ashley. The chain's ownership has included the COVID pandemic, when non-essential retailers were shut for prolonged periods, with Endless said to have supported the business financially during the pandemic. American Golf has shrunk modestly in size since the 2018 deal, with roughly 80% of the stores it acquired still trading. The retailer's likely valuation today is unclear. Read more from Sky News: It was previously owned by Sun European Partners, another investment firm, which acquired it from LDC, the private equity division of Lloyds Banking Group. Endless declined to comment on Friday.